San Diego Life Sciences 2030 Photo Gallery

San Diego Life Sciences 2030 NEXT IMAGE >>
Moderator John Mendlein (left), the chairman of Fate Therapeutics, got things off to a good start, saying “Let’s have some fun tonight.” Paul Schimmel of The Scripps Research Institute, who Mendlein called “the Bill Belichick of biotech” is at his right.
photo by Bob Buderi

Pages: Page 1, Page 2, Page 3, Page 4, Page 5, Page 6, Page 7, Page 8, Page 9, Page 10, Page 11, Page 12, Page 13, Page 14, Page 15, Page 16, Page 17

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.